|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
Statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
American Cancer Society: Breast Cancer -
Facts & Figures 2011–2012. American Cancer Society, Inc.
Atlanta, GA: 2011.http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-030975.pdf
|
|
3
|
Pasteris NG, Cadle A, Logie LJ, Porteous
ME, Schwartz CE, Stevenson RE, Glover TW, Wilroy RS and Gorski JL:
Isolation and characterization of the faciogenital dysplasia
(Aarskog-Scott syndrome) gene: A putative Rho/Rac guanine
nucleotide exchange factor. Cell. 79:669–678. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yamazaki D, Kurisu S and Takenawa T:
Regulation of cancer cell motility through actin reorganization.
Cancer Sci. 96:379–386. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nobes CD and Hall A: Rho, rac, and cdc42
GTPases regulate the assembly of multimolecular focal complexes
associated with actin stress fibers, lamellipodia, and filopodia.
Cell. 81:53–62. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mizuarai S, Kazunori Y and Hidehito K:
Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide
exchange factor-H1 for RhoA, resulting in accelerated cell
proliferation in tumor cells. Cancer Res. 66:6319–6326. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kourlas PJ, Strout MP, Becknell B,
Veronese ML, Croce CM, Theil KS, Krahe R, Ruutu T, Knuutila S,
Bloomfield CD and Caligiuri MA: Identification of a gene at 11q23
encoding a guanine nucleotide exchange factor: Evidence for its
fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA.
97:2145–2150. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ayala I, Giacchetti G, Caldieri G,
Attanasio F, Mariggiò S, Tetè S, Polishchuk R, Castronovo V and
Buccione R: Faciogenital dysplasia protein Fgd1 regulates
invadopodia biogenesis and extracellular matrix degradation and is
up-regulated in prostate and breast cancer. Cancer Res. 69:747–752.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forbes SA, Beare D, Gunasekaran P, Leung
K, Bindal N, Boutselakis H, Ding M, Bamford S, Cole C, Ward S, et
al: COSMIC: Exploring the world's knowledge of somatic mutations in
human cancer. Nucleic Acids Res. 43(Database issue): D805–D811.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orrico A, Galli L, Cavaliere ML, Garavelli
L, Fryns JP, Crushell E, Rinaldi MM, Medeira A and Sorrentino V:
Phenotypic and molecular characterization of the Aarskog-Scott
syndrome: A survey of the clinical variability in light of FGD1
mutation analysis in 46 patients. Eur J Hum Genet. 12:16–23. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Orrico A, Galli L, Faivre L, Clayton-Smith
J, Azzarello-Burri SM, Hertz JM, Jacquemont S, Taurisano R, Carrera
Arroyo I, Tarantino E, et al: Aarskog-Scott syndrome: Clinical
update and report of nine novel mutations of the FGD1 gene. Am J
Med Genet A. 152A:313–318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aarskog D: A familial syndrome of short
stature associated with facial dysplasia and genital anomalies. J
Pediatr. 77:856–861. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwartz CE, Gillessen-Kaesbach G, May M,
Cappa M, Gorski J, Steindl K and Neri G: Two novel mutations
confirm FGD1 is responsible for the Aarskog syndrome. Eur J Hum
Genet. 8:869–874. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Murugan AK, Yang C and Xing M: Mutational
analysis of the GNA11, MMP27, FGD1, TRRAP and GRM3 genes in thyroid
cancer. Oncol Lett. 6:437–441. 2013.PubMed/NCBI
|
|
16
|
Sambrook J and Russell DW: Purification of
nucleic acids by extraction with phenol: Chloroform. CSH Protoc.
2006:pii2006.
|
|
17
|
Cunningham F, Amode MR, Barrell D, Beal K,
Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G,
Fitzgerald S, et al: Ensembl 2015. Nucleic Acids Res. 43(Database
issue): D662–D669. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Untergrasser A, Cutcutache I, Koressaar T,
Ye J, Faircloth BC, Remm M and Rozen SG: Primer3 - new capabilities
and interfaces. Nucleic Acids Res. 40:e1152012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beadling C, Neff TL, Heinrich MC, Rhodes
K, Thornton M, Leamon J, Andersen M and Corless CL: Combining
highly multiplexed PCR with semiconductor-based sequencing for
rapid cancer genotyping. J Mol Diagn. 15:171–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sherry ST, Ward MH, Kholodov M, Baker J,
Phan L, Smigielski EM and Sirotkin K: dbSNP: The NCBI database of
genetic variation. Nucleic Acids Res. 29:308–311. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
1,000 Genomes Project Consortium. Abecasis
GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, Kang
HM, Marth GT and McVean GA: An integrated map of genetic variation
from 1,092 human genomes. Nature. 491:56–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fu W, O'Connor TD, Jun G, Kang HM,
Abecasis G, Leal SM, Gabriel S, Rieder MJ, Altshuler D, Shendure J,
et al: Analysis of 6,515 exomes reveals the recent origin of most
human protein-coding variants. Nature. 493:216–220. 2013.
View Article : Google Scholar : PubMed/NCBI
|
